Despite advances in screening and treatment, HDFN remains a significant cause of perinatal morbidity and mortality worldwide.

Advancements in research and ongoing clinical trials related to HDFN prevention and treatment can change HDFN care for the ...

Moving during a high-risk pregnancy can feel stressful, but there are ways you can prepare beforehand to help the move go ...

Comprehensive Rh blood typing and genetic analysis can help prevent HDFN and reduce transfusion-related complications.

This registry offers a valuable opportunity to collect comprehensive prospective data on HDFN outcomes across diverse clinical settings. A global non-interventional registry study is underway to ...

A non-invasive test for Rhesus HDFN during pregnancy can allow for better screening of at-risk women. The program was established to offer RHD screening services to pregnant women who were Rhesus D ...

A pregnant woman’s rare anti-Lub antibody, which can trigger mild HDFN, went undetected due to limited medical record connectivity between health systems. Improved data sharing across blood banks ...

The panel ultimately agreed on 15 recommendations for evaluating high-risk patients for HDFN. A group of Canadian experts recently developed a set of recommendations for preventing and treating ...

Babies who received intrauterine transfusions before birth had the greatest risk of iron overload. Infants with hemolytic disease of the fetus and newborn (HDFN) caused by Rh incompatibility are often ...

Researchers have identified a rare RHD blood variant that can cause anti-D antibody formation and increase the risk of HDFN. A newly identified blood variant found predominantly in Indigenous ...

Neonates who received IUTs after 34 weeks gestation were less likely to need exchange transfusions and less likely to be born ...